-
The mutational landscape and its longitudinal dynamics in relapsed and refractory Hodgkin lymphoma
Study
EGAS50000000149
-
Longitudinal sampling in relapsed and refractory Hodgkin lymphoma
Dataset
EGAD50000000210
-
Longitudinal dynamics in relapsed and refractory Hodgkin lymphoma Data Commitee
Dac
EGAC50000000108
-
Agilent Sarcoma cohort
Dataset
EGAD50000000073
-
CRUK Oesophageal Adenocarcinoma Neoantigen Data Access Commitee
Dac
EGAC00001002496
-
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease
Study
EGAS50000000215
-
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease
Dataset
EGAD50000000310
-
Servicio Hematología_Hospital Universitario de Salamanca_Spain
Dac
EGAC50000000155
-
Karyotype Evolution in Response to Chemoradiotherapy and Upon Recurrence of Esophageal Adenocarcinomas
Study
EGAS00001007711
-
Single-cell profiling reveals mechanisms of response to anti-PD-L1 versus anti-PD-L1 combined with anti-CTLA4 in head and neck squamous cell carcinoma
Study
EGAS50000000037
-
Ovarian carcinoma
Dataset
EGAD50000000219
-
Unraveling the genetics of transformed splenic marginal zone lymphoma
Study
EGAS00001006389
-
MediMer: A versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection
Study
EGAS50000000065
-
Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway
Study
EGAS50000000136
-
Pediatric HGG panel sequencing
Dataset
EGAD50000000326
-
Diffuse Midline Glioma Proteomics Data Access Committee
Dac
EGAC00001003296
-
DNA sequences from adolescent and young adult patients with melanoma treated with immunotherapy
Dataset
EGAD50000000353
-
RNA-seq dataset
Dataset
EGAD50000000347
-
scRNA sequencing of in vitro generated suppressive myeloid cells using parental and Sialidase expressing A549 cancer cell lines
Dataset
EGAD50000000351
-
A neoadjuvant, phase II trial demonstrates efficacy and tolerability of Talimogene laherparepvec in cutaneous basal cell carcinoma (NeoBCC trial)
Dataset
EGAD50000000371
-
A proof-of-concept study of sequential treatment with the HDAC inhibitor vorinostat following BRAF and MEK inhibitors in BRAFV600 mutated melanoma
Study
EGAS00001007709
-
Single-cell RNA-seq of immune cell subsets isolated from human tumors (Kaptein et al., 2024)
Dataset
EGAD50000000376
-
Single-cell RNA-seq of immune cells from human tumor fragments after 48 hour culture ex vivo (Kaptein et al., 2024)
Dataset
EGAD50000000377
-
DNA sequening
Dataset
EGAD50000000382
-
RNA sequencing
Dataset
EGAD50000000383
-
Longitudinal 3'RNA-Seq data from MEMORI trial
Dataset
EGAD50000000357
-
Longitudinal WES data from MEMORI trial
Dataset
EGAD50000000355
-
Medulloblastoma RNAseq
Study
EGAS50000000262
-
TCRseq
Dataset
EGAD50000000379
-
WES
Dataset
EGAD50000000380
-
Medulloblastoma dataset
Dataset
EGAD50000000384
-
Neversmoker lung adenocarcinoma
Study
EGAS50000000232
-
RNAseq of preneoplasia lung adenocarcinoma
Study
EGAS50000000271
-
Whole genome sequencing of preneoplasia lung adenocarcinoma
Study
EGAS50000000272
-
Whole exome sequencing of preneoplasia lung adenocarcinoma
Study
EGAS50000000270
-
Korean WGS
Dataset
EGAD50000000346
-
RNAseq of preneoplasia lung adenocarcinoma
Dataset
EGAD50000000395
-
Whole genome sequencing of preneoplasia lung adenocarcinoma
Dataset
EGAD50000000396
-
Whole exome sequencing of preneoplasia lung adenocarcinoma
Dataset
EGAD50000000397
-
Gene expression profiling of HGCC patient-derived Glioblastoma Cell Lines (ISPA-GBM)
Study
EGAS00001006814
-
Enhancing OSCC Prediction: The Prognostic Power of WPOI and Tumor Budding, and the Limited Impact of Molecular Resection Margins
Study
EGAS50000000074
-
Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient
Study
EGAS50000000102
-
RNA-Seq data from tumor samples collected from 12 UTSW translocation renal cell carcinoma (tRCC) patients.
Study
EGAS50000000127
-
WES data from tumors and matching controls collected from 11 UTSW translocation renal cell carcinoma (tRCC) patients.
Study
EGAS50000000126
-
Whole exome sequencing of pediatric soft tissue sarcoma PDX models
Study
EGAS50000000048
-
Comprehensive spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Study
EGAS50000000220
-
Whole exome sequencing of FFPE material from 41 pediatric BCP-LBL patients.
Study
EGAS50000000290
-
Whole exome RNA sequencing of FFPE material from 49 pediatric BCP-LBL patients.
Study
EGAS50000000289
-
DAC for BCP-LBL Kiel
Dac
EGAC50000000181
-
PRADO trial - Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab plus nivolumab in stage III melanoma
Dataset
EGAD50000000393